METHODS FOR DETERMINING THE LIKELIHOOD OF LUNG CANCER
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Dec 15, 2022
app pub date -
Jun 19, 2020
filing date -
Jun 19, 2020
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
The present invention is directed to a method of determining the likelihood of the presence of lung cancer in a subject. The method comprising determining the level of a biomarker selected from the group consisting of catalase (CAT), C-X-C motif chemokine receptor 4 (CXCR4), superoxide dismutase 3 (SOD3) and surfactant protein B (SFTPB) from a vesicle population isolated from a biological sample from said subject, wherein a change in the level of biomarker as compared to a reference indicates the likelihood of the presence of lung cancer in the subject.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully